BRCA2-deficient HCT-15 cells and BRCA-proficient RKO cells were subcutaneously injected into nude mice, and once tumor volume reached ~70 mm3, either simmiparib or LY2090314, alone or in combination, was injected every other day for 14 days. Here, BRCA2 is linked to neoplasm.